All companies › SKYE

SKYE · Skye Bioscience, Inc.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells8
Research cases0
Last filing2026-09-23

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-09-22 — ROCKLAGE SCOTT M · sold 1,088 @ $1.65 2026-09-22 — ROCKLAGE SCOTT M · sold 27,612 @ $1.65 2026-09-22 — Schwab Andrew J. · sold 1,088 @ $1.65 2026-09-22 — Schwab Andrew J. · sold 27,612 @ $1.65 2026-09-23 — ROCKLAGE SCOTT M · sold 114,851 @ $1.61 2026-09-23 — ROCKLAGE SCOTT M · sold 4,528 @ $1.61 2026-09-23 — Schwab Andrew J. · sold 114,851 @ $1.61 2026-09-23 — Schwab Andrew J. · sold 4,528 @ $1.61
2026-09-222026-09-23

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

ROCKLAGE SCOTT M 10% owner
Schwab Andrew J. Director, 10% owner
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $SKYE is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-09-23', 'insider_name': 'ROCKLAGE SCOTT M', 'insider_title': '10% owner', 'transaction_type': 'Open-market sell', 'shares': 114851.0, 'price': 1.61, 'value': 184910.11, 'is_buy': False}, {'transaction_date': '2026-09-23', 'insider_name': 'ROCKLAGE SCOTT M', 'insider_title': '10% owner', 'transaction_type': 'Open-market sell', 'shares': 4528.0, 'price': 1.61, 'value': 7290.08, 'is_buy': False}, {'transaction_date': '2026-09-23', 'insider_name': 'Schwab Andrew J.', 'insider_title': 'Director, 10% owner', 'transaction_type': 'Open-market sell', 'shares': 114851.0, 'price': 1.61, 'value': 184910.11, 'is_buy': False}, {'transaction_date': '2026-09-23', 'insider_name': 'Schwab Andrew J.', 'insider_title': 'Director, 10% owner', 'transaction_type': 'Open-market sell', 'shares': 4528.0, 'price': 1.61, 'value': 7290.08, 'is_buy': False}, {'transaction_date': '2026-09-22', 'insider_name': 'ROCKLAGE SCOTT M', 'insider_title': '10% owner', 'transaction_type': 'Open-market sell', 'shares': 1088.0, 'price': 1.65, 'value': 1795.2, 'is_buy': False}, {'transaction_date': '2026-09-22', 'insider_name': 'ROCKLAGE SCOTT M', 'insider_title': '10% owner', 'transaction_type': 'Open-market sell', 'shares': 27612.0, 'price': 1.65, 'value': 45559.8, 'is_buy': False}, {'transaction_date': '2026-09-22', 'insider_name': 'Schwab Andrew J.', 'insider_title': 'Director, 10% owner', 'transaction_type': 'Open-market sell', 'shares': 1088.0, 'price': 1.65, 'value': 1795.2, 'is_buy': False}, {'transaction_date': '2026-09-22', 'insider_name': 'Schwab Andrew J.', 'insider_title': 'Director, 10% owner', 'transaction_type': 'Open-market sell', 'shares': 27612.0, 'price': 1.65, 'value': 45559.8, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for SKYE today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.